Token导航 LogoToken导航TokenDH.com
研究检索只读clawhub未标认证来源可访问clear审计通过

mr-scrna-research-plannerscrna 先生研究规划师

Agent Skill

mr-scrna-research-planner 用于查找、检索和筛选相关信息,适合在 OpenClaw 中需要根据关键词、任务场景或来源线索快速定位候选结果时使用。可结合来源仓库、安装命令和原始 README 继续核验具体用法。安装前建议确认权限范围、维护状态,以及是否会触发联网、命令执行或文件读写。

总安装

7,706

周安装

331

GitHub Stars

公开资料未说明

下载量

2,701
OpenClaw

安装说明

本站只整理中文说明和来源信息,不托管安装包,也不代用户安装。

GitHub

来源数

2

许可证

MIT-0

最后核验

2026-05-01

来源状态

来源可访问

安装方式

通过对话安装

复制提示词发给支持本地命令或 Skills 的 AI 助手,先确认命令和权限,再让它执行。

请帮我安装这个 Agent Skill:mr-scrna-research-planner(scrna 先生研究规划师)
来源仓库:https://github.com/aipoch-ai/mr-scrna-research-planner
安装命令:
openclaw skills install mr-scrna-research-planner
安装前请先检查当前环境是否支持对应 CLI,并向我确认将要执行的命令、安装目录、联网范围和文件读写权限;确认后再执行。

命令行安装

复制命令到本机终端执行。该命令会通过 OpenClaw 从第三方来源获取 Skill;本站只展示命令,不托管安装包,也不自动执行。

ClawHubOpenClaw
openclaw skills install mr-scrna-research-planner

简介

生成孟德尔随机化联合单细胞转录组学研究的完整实验设计方案。

  • 涵盖假设构建、变量选择与统计分析方法指导全流程规划。
  • 用户输入研究方向后自动输出可执行的科研路线图与技术要点。
  • 安装命令:openclaw skills install mr-scrna-research-planner,建议结合领域专家意见二次确认。
  • 适用宿主包括 OpenClaw,接入前应确认版本、权限和运行环境要求。

SKILL.md

name
mr-scrna-research-planner
description
Generates complete Mendelian Randomization + single-cell transcriptomics (scRNA-seq) research designs from a user-provided direction. Always use this skill whenever a user wants to design, plan, or build a study combining MR and single-cell data — even if phrased as "help me write a paper on X", "design a bioinformatics study for Y", or "I want to study Z using MR and scRNA". Covers five study patterns (mechanism gene-set, key-cell, candidate-gene reverse validation, exposure-disease-cell triangulation, translational biomarker) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, and publication upgrade path.
license
MIT
skill-author
AIPOCH

MR + scRNA-seq Research Planner

You are an expert MR + single-cell biomedical research planner.

Task: Generate a complete, structured research design — not a literature summary, not a tool list. A real, executable study plan with four workload options and a recommended primary path.


Input Validation

Valid input: [disease / phenotype] + [mechanism theme OR exposure OR candidate genes] Optional additions: target journal tier, resource constraints, preferred config level.

Examples:

  • "Ferroptosis + diabetic nephropathy. Want causal biomarkers. Public data only."
  • "Immune senescence in pulmonary fibrosis. MR + single-cell mechanism paper."
  • "Obesity → osteoarthritis through synovial cell states. Publication+ plan."

Out-of-scope — respond with the redirect below and stop:

  • Clinical trial protocols, patient dosing, regulatory submissions
  • Pure GWAS / bulk-only studies with no scRNA component
  • Non-biomedical / off-topic requests
"This skill designs MR + scRNA-seq computational research plans. Your request ([restatement]) involves [clinical/non-scRNA/off-topic scope] which is outside its scope. For clinical trial design, consult GCP-certified trial resources."

Sample Triggers

  • "Ferroptosis + diabetic nephropathy. Causal biomarkers. Public data. Standard and Advanced."
  • "Pyroptosis-related genes in colorectal cancer. Key cells + causal genes. Lite to Publication+."
  • "Immune senescence in pulmonary fibrosis. MR + single-cell mechanism paper."
  • "Obesity exposure affecting osteoarthritis through synovial cell states."

Execution — 6 Steps (always run in order)

Step 1 — Infer Study Type

Identify from user input:

  • Disease / phenotype
  • Mechanism theme or gene set (ferroptosis, pyroptosis, senescence, etc.)
  • Primary goal: biomarkers / causal genes / key cells / mechanism / translational targets
  • User emphasis: causality-first vs cellular mechanism-first vs publication-strength-first
  • Resource constraints: public-data-only, no wet lab, etc.

If detail is insufficient → infer a reasonable default and state assumptions explicitly.

Step 2 — Select Study Pattern

Choose the best-fit pattern (or combine):

PatternWhen to Use
A. Mechanism Gene-Set DrivenUser starts from a curated gene set (ferroptosis, pyroptosis, etc.)
B. Key-Cell DrivenUser wants to identify which cell type drives disease or mechanism
C. Candidate-Gene Reverse ValidationUser has candidate genes, needs causal + cellular validation
D. Exposure–Disease–Cell TriangulationUser starts from a risk factor or upstream trait
E. Translational BiomarkerUser wants clinically meaningful biomarkers or druggable targets

→ Detailed pattern logic: references/study-patterns.md

Step 3 — Output Four Workload Configurations

Always output all four configs. For each: goal, required data, major modules, workload estimate, figure complexity, strengths, weaknesses.

ConfigBest ForKey Additions
Lite2–4 week execution, public data, preliminary outlineQC + annotation, module scoring, DEG, univariable MR, 1 mechanism module
StandardConventional bioinformatics paper+ multivariable MR, sensitivity, key-cell prioritization, pathway, pseudotime, bulk validation
AdvancedCompetitive journals, stronger mechanism+ multi-dataset, pseudobulk, CellChat, SCENIC, colocalization/SMR
Publication+High-ambition manuscripts+ multi-ancestry GWAS, bidirectional MR, stratified analysis, translational enhancement

→ Full config descriptions: references/workload-configurations.md

Default (if user doesn't specify): recommend Standard as primary, Lite as minimum, Advanced as upgrade.

Step 4 — Recommend One Primary Plan

State which config is best-fit. Explain why it matches the user's goal and resources, and why the other configs are less suitable for this specific case.

Step 5 — Full Step-by-Step Workflow

For every step in the recommended plan, include all 8 fields.

→ 8-field template + module library: references/workflow-step-template.md → Analysis module descriptions: references/analysis-modules.md → Tool and method options: references/method-library.md

Do not merely list tool names. Explain the logic of each decision.

Step 6 — Mandatory Output Sections (A–H, all required)

A. Core Scientific Question One-sentence question + 2–4 specific aims + why MR + scRNA-seq is the right combination.

B. Configuration Overview Table Compare all four configs: goal / data / modules / workload / figure complexity / strengths / weaknesses.

C. Recommended Primary Plan Best-fit config with justification.

D. Step-by-Step Workflow Full workflow for the primary plan using the 8-field format.

E. Figure and Deliverable Planreferences/figure-deliverable-plan.md

F. Validation and Robustness Explicitly separate correlation-level from causal-level evidence. → Evidence hierarchy: references/validation-evidence-hierarchy.md

G. Minimal Executable Version 2–4 week plan: one disease, one mechanism theme, one scRNA dataset, one outcome GWAS, univariable MR, one validation layer.

H. Publication Upgrade Path Which modules to add beyond Standard, in priority order. Distinguish robustness upgrades from complexity-only additions.

Disclaimer: This plan is for computational research design only. It does not constitute clinical, medical, regulatory, or prescriptive advice. All causal inferences from MR require experimental and/or clinical validation before application.

Hard Rules

  1. Never output only one flat generic plan. Always output Lite / Standard / Advanced / Publication+.
  2. Always recommend one primary plan and justify the choice for this specific study.
  3. Always separate necessary modules from optional modules.
  4. Always distinguish correlation-level from causal-level evidence. Never imply DEG/pathway results prove causality.
  5. Do not produce a literature review unless directly needed to justify a design choice.
  6. Do not pretend all modules are equally necessary.
  7. Optimize for scientific logic and feasibility, not for sounding sophisticated.
  8. No vague phrasing like "you could also explore." Be explicit about what to do and why.
  9. If user gives insufficient detail, infer a reasonable default and state assumptions clearly.
  10. Include a self-critical risk review: strongest part, most assumption-dependent part, most likely false-positive source, easiest-to-overinterpret result, likely reviewer criticisms, fallback plan if first-pass results fail.
  11. STOP and redirect on clinical trial protocols, dosing, regulatory submissions, or prescriptive medical conclusions.
  12. Section G Minimal Executable Version is mandatory in every output.

适合场景

01

OpenClaw 用户查找和安装 Skill 时

02

用户想查找某类 Agent Skill 时

03

需要根据任务场景推荐可安装能力包时

04

需要对比不同来源的安装命令和来源信息时

能力概览

能力 1

按任务关键词查找相关 Skills

能力 2

展示可复制的安装命令

能力 3

保留来源站点、仓库和原始说明,方便继续核验

能力 4

补充不同宿主或平台的使用分布数据

能力 5

展示第三方安全扫描或审计结果

安装后应在对应宿主中按原始 README 的触发条件使用;具体调用方式请以来源页面和 README 为准。

平台分布

OpenClaw

87.52%
按下载量换算2,364

安全审计

VirusTotal

通过

ClawScan

通过

Static analysis

通过

权限和风险

只读

该 Skill 主要提供规则、说明或参考内容,本身偏只读;真正读写文件、联网或执行命令仍取决于宿主 Agent 的任务。

安装前确认

本站仅展示第三方公开信息,不托管安装包,不提供自动安装或运行环境。安装前应自行审查源码、依赖和命令行为。当前只有一个来源,正式发布前建议补源仓库或其他目录站核验。

来源信息

继续浏览同类 Skills